Bionano Genomics (BNGO) Depreciation and Depletion (2024 - 2026)

Bionano Genomics has disclosed Depreciation and Depletion across 3 years of filings, most recently posting $1.0 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $1.0 million, down 9.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 1.54% YoY), and the FY2025 annual result was $4.2 million, down 14.29% from the prior year.
• Depreciation and Depletion came in at $1.0 million for Q1 2026 at Bionano Genomics, up from -$1.1 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.4 million in Q4 2024 to a low of -$1.1 million in Q2 2025.
• The 3-year median for Depreciation and Depletion is $1.0 million (2026), against an average of $1.2 million.
• Across the five-year window, Depreciation and Depletion soared 320.0% in 2025 and decreased 9.09% in 2026, its largest moves.
• Bionano Genomics' Depreciation and Depletion stood at $5.4 million in 2024, then plunged by 120.37% to -$1.1 million in 2025, then soared by 190.91% to $1.0 million in 2026.
• The last three Depreciation and Depletion figures came in at $1.0 million (Q1 2026), -$1.1 million (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.